Go to the list of all blogs
Allana's Avatar
published in Blogs
Nov 21, 2026
TickeronGET DAILY SIGNALS
Caesars Entertainment (CZR) Acquisition Sets $31 Target with Modest +6.7% Gap Remaining

Caesars Entertainment (CZR) Acquisition Sets $31 Target with Modest +6.7% Gap Remaining

Key Takeaways

  • The central $31 target is the all-cash price in Fertitta Entertainment's pending acquisition of Caesars Entertainment, Inc. (CZR), not a fundamental analyst upside estimate.
  • Announced in May 2026 and approved by shareholders on September 22, 2026, the deal values Caesars at about $17.6 billion, including roughly $11.9 billion of assumed debt.
  • With the stock around $29.06, reaching $31 requires a modest gain of about 6.7% — a gap that largely reflects merger-arbitrage and regulatory risk rather than operating upside.
  • Covering analysts have converged on $31, the deal price, with a consensus Hold rating; a handful of pre-merger targets still ranged from roughly $26 to $35.
  • The strongest support is the certainty of the cash consideration and completed shareholder approval; the biggest risk is the Federal Trade Commission's (FTC) "second request," which extends antitrust review.
  • Because the buyout caps the realistic price objective near $31, the central target sits below the 10% threshold normally used for fundamental upside cases and is framed as a merger-price objective.

How Analyst Targets Shifted After the Deal Announcement

Caesars Entertainment's analyst coverage has been reshaped by the pending transaction. Since the buyout was announced in May 2026, price targets from firms including Barclays, Stifel, J.P. Morgan, Susquehanna, Wells Fargo, and TD Cowen have converged on $31 — the cash offer — accompanied by a wave of downgrades to Hold or Neutral. The consensus rating across more than a dozen covering analysts is Hold, and the average price target is approximately $31, according to data compiled by MarketWatch, Barron's, and TipRanks. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Before the deal, targets were scattered: some firms carried $26 figures, while Morgan Stanley had a $34 target and Citizens JMP a $35 target. Those pre-merger levels are now largely moot. In other words, the $31 "target" is not a forecast of fundamental value but a reflection of the agreed merger consideration.

Current Market Position and Path Toward the Target

The stock closed near $29.06, putting the $31 objective roughly 6.7% higher — a modest gap. It has traded as high as $30.88 over the past 52 weeks, just beneath the offer price, after recovering from a 52-week low of $17.86. The path to $31 runs almost entirely through the regulatory process rather than operations. Caesars shareholders approved the merger with 65.4% of outstanding shares voting in favor on September 22, 2026. The remaining obstacle is the FTC, which issued a second request for information on September 14, 2026, extending the Hart-Scott-Rodino waiting period. The company reported third-quarter revenue of about $2.94 billion and a GAAP net loss of $123 million, and it remains unprofitable on a GAAP basis — but those fundamentals matter less than whether the deal closes.

Factors That Could Support a Move Toward the Target

  • Completed shareholder approval removes one major source of uncertainty.
  • The all-cash, $31-per-share structure gives holders a defined exit value.
  • The FTC requested more information rather than suing to block the deal, and both parties have said they will cooperate.
  • Management continuity is planned, with CEO Tom Reeg and the existing leadership team expected to remain in place.

Risks That Could Prevent Reaching the Target

  • The FTC's second request can extend the timeline by months and could require asset sales or other remedies.
  • A deal break would return the stock to standalone trading, exposing holders to operating weakness and the company's heavy debt load.
  • Fertitta is assuming nearly $12 billion in debt, adding financial risk to the combined entity.
  • Standalone fundamentals show GAAP losses and margin pressure, which would weigh on the stock if the transaction were terminated.

Technical Levels and Market Structure

The 52-week high of $30.88 sits just under the $31 offer, effectively capping the stock while the deal is pending. The shares have consolidated in the high $20s during the regulatory review, with the $29 area serving as a near-term reference and $31 acting as a hard ceiling tied to the cash consideration.

Time Horizon and What Investors Should Monitor

Analyst price targets ordinarily reflect a 12-month research horizon, but here the relevant clock is the merger timeline. Key items to watch include the FTC's review and any compliance milestones under the second request, the 30-day post-compliance waiting period, and any required divestitures. The merger agreement includes a ticking fee of $0.007150 per share per day if closing slips beyond June 26, 2027. Caesars' next earnings release and any update on deal financing or renegotiation also remain important. From what I see, monitoring these regulatory steps is central to assessing the position.

Using AI Tools in Merger Analysis

Tickeron's AI Daily Buy/Sell Signals have become a regular part of my process for situations like this. The platform applies artificial intelligence to scan thousands of stocks and ETFs, delivering Buy, Sell, or Hold signals based on technical behavior and market shifts. In a merger-arbitrage setup such as Caesars, these signals help cut through noise and keep track of broader sector trends without constant manual checks. I find the approach useful for confirming timing around regulatory updates or position adjustments.

Final Assessment

Caesars Entertainment (CZR) is less a fundamental-upside story than a merger-arbitrage situation. The $31 central target is the all-cash acquisition price, and the stock's roughly 6.7% discount to it reflects the market's assessment that the deal may be delayed or, less likely, not close. The strongest supports are completed shareholder approval and the fixed cash consideration; the principal obstacles are the FTC's extended review and the company's high leverage. What matters next is not earnings growth but the regulatory path and any closing conditions. Investors should weigh the modest remaining premium against the risk that the transaction is modified or abandoned.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CZR

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


CZR's RSI Oscillator ascending out of oversold territory

The RSI Indicator for CZR moved out of oversold territory on October 29, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 37 similar instances when the indicator left oversold territory. In 31 of the 37 cases the stock moved higher. This puts the odds of a move higher at 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CZR just turned positive on November 02, 2026. Looking at past instances where CZR's MACD turned positive, the stock continued to rise in 38 of 52 cases over the following month. The odds of a continued upward trend are 73%.

Following a +0.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where CZR advanced for three days, in 196 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

CZR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 47 of 62 cases where CZR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 76%.

The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CZR as a result. In 73 of 105 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CZR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.

The Aroon Indicator for CZR entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.765) is normal, around the industry mean (14.575). P/E Ratio (-12.877) is within average values for comparable stocks, (53.870). CZR's Projected Growth (PEG Ratio) (4.468) is very high in comparison to the industry average of (0.784). Dividend Yield (0.000) settles around the average of (0.022) among similar stocks. P/S Ratio (0.522) is also within normal values, averaging (1.049).

The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. CZR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 45 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CZR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are Las Vegas Sands Corp (NYSE:LVS), Wynn Resorts Limited (NASDAQ:WYNN), MGM Resorts International (NYSE:MGM), Melco Resorts & Entertainment Limited (NASDAQ:MLCO).

Industry description

The industry includes companies that operate and manage one or more of the following: lodging facilities (e.g. hotels and motels), resorts (e.g. ski resorts), spas, cruise ships and timeshare facilities. Marriott International, Inc., Carnival Corporation, Hilton Worldwide Holdings Inc. and Royal Caribbean Cruises Ltd. are some of the biggest names in this industry.

Market Cap

The average market capitalization across the Hotels/Resorts/Cruiselines Industry is 4.54B. The market cap for tickers in the group ranges from 514.43K to 26.38B. LVS holds the highest valuation in this group at 26.38B. The lowest valued company is CNDL at 514.43K.

High and low price notable news

The average weekly price growth across all stocks in the Hotels/Resorts/Cruiselines Industry was -7%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -17%. MSC experienced the highest price growth at 13%, while CNTY experienced the biggest fall at -58%.

Volume

The average weekly volume growth across all stocks in the Hotels/Resorts/Cruiselines Industry was 57%. For the same stocks of the Industry, the average monthly volume growth was 22% and the average quarterly volume growth was -5%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 53
Price Growth Rating: 59
SMR Rating: 70
Profit Risk Rating: 92
Seasonality Score: 23 (-100 ... +100)
1-on-1 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an operator of hotels and casinos

Industry HotelsResortsCruiselines

Industry
Casinos Or Gaming
Address
100 West Liberty Street
Phone
+1 775 328-0100
Employees
50000
Web
https://www.caesars.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.